The initial macrophage-Leishmania donovani interaction results in the formation of membrane platforms, termed lipid rafts, that help in the entry of the parasite. Therefore, it is imperative that the parasite designs a strategy to modulate its uptake and survival within the macrophages. Herein, we report Leishmania-triggered biphasic ceramide generation. In the first phase, L. donovani promastigotes induce activation of acid sphingomyelinase (ASMase), which catalyzes the formation of ceramide from sphingomyelin. Inhibition of ASMase resulted in reduced uptake and infection with the parasite. In the second phase, de novo synthesis generates ceramide that reduces the cellular cholesterol level and displaces the cholesterol from the membrane, leading to enhanced membrane fluidity, disruption of rafts, and impaired antigen-presentation to the T cells. The results reveal a novel role for ceramide in the perspective of L. donovani infection and help formulate an antileishmanial strategy that can possibly be applied to other intracellular infections as well.
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The initial macrophage-Leishmania donovani interaction results in the formation of membrane platforms, termed lipid rafts, that help in the entry of the parasite. Therefore, it is imperative that the parasite designs a strategy to modulate its uptake and survival within the macrophages. Herein, we report Leishmania-triggered biphasic ceramide generation. In the first phase, L. donovani promastigotes induce activation of acid sphingomyelinase (ASMase), which catalyzes the formation of ceramide from sphingomyelin. Inhibition of ASMase resulted in reduced uptake and infection with the parasite. In the second phase, de novo synthesis generates ceramide that reduces the cellular cholesterol level and displaces the cholesterol from the membrane, leading to enhanced membrane fluidity, disruption of rafts, and impaired antigen-presentation to the T cells. The results reveal a novel role for ceramide in the perspective of L. donovani infection and help formulate an antileishmanial strategy that can possibly be applied to other intracellular infections as well.
Leishmania amastigotes are obligatorily intracellular protozoan parasites that reside and replicate within the macrophages of their mammalian host. The parasite survives by modulating host-cell signaling from various cell membrane receptors [1] [2] [3] . Therefore, it has 2 important phases in its survival: quick uptake by the host cell and survival once internalized. It has been shown recently that pretreatment of macrophages with β-methyl cyclodextrin (βMCD) or nystatin, which destroys small sphingolipid-and cholesterolenriched membrane rafts, inhibits Leishmania internalization [4] [5] [6] . On the other hand, cholesterol is depleted from the membrane of the Leishmaniainfected macrophages, causing disruption of the lipid raft [7] . Lipid rafts are stabilized by ceramide molecules [8] [9] [10] , which separate spontaneously from other phospholipids and seem to exist as preformed entities in the cell membrane. Thus, these apparently contrasting observations provide a paradox with regard to the role of cholesterol and ceramide. However, the functions of ceramide-enriched membrane domains and the relationship of ceramide with membrane cholesterol in Leishmania infection of macrophages remain unknown. Ceramide is a membrane lipid involved in many biological processes. Recent studies suggest that ceramide, a pleiotropic lipid molecule, plays a pivotal role in the establishment of pathogens inside host cells [11] [12] [13] . Ceramide-enriched membrane platform formation is initiated by activation of acid sphingomyelinase (ASMase), which has been shown to be stimulated by several receptors [14, 15] and by pathogenic bacteria and viruses [16] [17] [18] [19] . These stimuli not only activate the enzyme but also induce the translocation of ASMase from an intracellular compartment to the extracellular leaflet of the cell membrane [20] . The hydrolysis of the membrane sphingomyelin by ASMase results in the generation of ceramide [21] .
Ceramide is generated either by this catabolic pathway or by de novo synthesis [22] . Previous work from our laboratory demonstrated that infection with Leishmania donovani increases the de novo synthesis of ceramide in macrophages [11] , which alters the normal antimicrobial machinery of the macrophages and helps in the establishment of parasite inside the cells.
Here, we demonstrate for the first time that Leishmania triggers a biphasic induction of ceramide and that L. donovani induces ASMase activation and the first phase of ceramide generation. The ceramide-enriched membrane platforms are then used for the parasite internalization. While the internalized parasites are transformed into amastigotes, the ceramide produced by de novo synthesis displaces the cholesterol from the membrane, enhancing the membrane fluidity but reducing antigen presentation to the T cells. The results indicate the bimodal generation of ceramide, associating each process to a particular function in macrophages. While the initial ASMase-dependent generation of ceramide is important for parasite uptake, the de novo synthesis of ceramide associates with the antigenpresenting function of macrophages. The model of Leishmania infection exemplifies how the dual regulation of ceramide can on, one hand, be targeted for therapeutics and, on the other hand, be targeted by the parasite to devise an immune evasion strategy.
MATERIALS AND METHODS

Materials
Anti-ceramide antibody (15B4; dilution, 1:50) was a kind gift from Prof. E. Gulbins (University of Essen, Germany). The peptide LEDARRLKAIYEKKK (12-26 residues of λ repressor protein [λR [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] ) and fetal bovine serum (FBS) were obtained from Invitrogen Life Technologies. Tissue culture reagents were from Gibco Laboratories. All other chemicals were from Sigma or Merck.
Methods
The λR 12-26 -specific I-A d -restricted T-cell hybridoma 9H3.5 [23] was a kind gift from Prof. M.L. Gefter (MIT, Cambridge, MA). The interleukin 2 (IL-2)-dependent cell line HT-2 was from ATCC. All cells were maintained in Roswell Park Memorial Institute 1640 medium with 10% FBS and 2-ME (5 × 10 -5 M) at 5% CO 2 in a humidified atmosphere. BALB/c mice aged 4-6 weeks (National Center for Laboratory Animal Sciences, India) were used for each experiment, with 8-10 mice/group. Stationary-phase L. donovani (MHOM/IN/1983/AG83) promastigotes were used for infection. Amastigotes were prepared as described elsewhere [24] . Thioglycollate-elicited peritoneal macrophages were cultured as described by Fahey et al. [25] .
The micellar ASMase assay involving exogenous radiolabeled SM was performed using the methods of Quintern and Sandhoff [26] . Ceramide synthase activity that involved exogenous radiolabeled [ 14 C] palmitoyl-CoA was measured as previously described [27] . The ceramide assay was carried out with radiolabeled stearic acid, using the methods of Gamen et al. [28] . Following the manufacturer's protocol, total RNA from macrophages was extracted in TRI Reagent (Sigma). Isolated RNA was reverse transcribed using Revert Aid M-MuLV Reverse Transcriptase (Fermentas). The resulting complementary DNA was used for real-time polymerase chain reaction (PCR) to detect 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), using ABI 7500 real-time PCR with SYBR green dye (Applied Biosystems). Glyceraldehyde-3 phosphate dehydrogenase (GAPDH) was used as a reference. The forward and reverse primer sequences were as follows: HMGCR: forward 5′-ACAATAAGATCTGTGGTTGGAATTATGA-3′ and reverse 5′-GCTATGCATCGTGTTATTGTCAGAA-3′; GAPDH: forward 5′-CAAGGCTGTGGGCAAGGTCA-3′ and reverse 5′-AGGTGGAAGAGTGGGAGTTGCTG-3′. Relative changes in HMGCR expression were determined on the basis of a comparison with unstimulated control, were normalized to GAPDH, and were quantified by the 2 −ddCt method.
Total and membrane-specific cholesterol content in uninfected and infected macrophages were assayed with use of the Amplex Red cholesterol assay kit (Invitrogen). The assay was performed according to the manufacturer's instructions.
Control and infected macrophages were harvested, washed, and resuspended in cold wash buffer (phosphate-buffered saline/0.1% NaN 3 /1% FBS), centrifuged at 350g for 5 minutes, and resuspended in 50 µL of wash buffer [29] . Cells were stained with fluorochrome-conjugated antibodies according to the manufacturer's protocol. The cells were then fixed with 1% paraformaldehyde, mounted with 90% glycerol on a glass slide, and observed under a laser-scanning microscope (LSM 510; Zeiss).
Macrophages were stained with anti-ceramide mouse monoclonal antibody (dilution, 1:50) followed by FITC-conjugated anti-mouse secondary antibody [17] . The cells were analyzed on a FACS Calibur.
The membrane fluorescence and lipid fluidity of cells were measured in accordance with the method described by Shinitzky and Inbar [30, 31] The antigen-presenting ability of macrophages was studied by their ability to present λR [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] to T-cell hybridoma (9H 3.5) and produce IL-2, as described originally by Roy et al. [24] .
Statistical Analysis
The data, represented as mean ± SD, are from 1 experiment, which was performed at least 3 times. The Student t test was used to assess the significance of the differences between the mean values of control and experimental groups. At least 6 mice were included per group for the experiments in vivo.
RESULTS
L. donovani Induces Sphingolipid-Enriched Platforms on the Macrophage Membrane
To determine whether sphingolipid-rich membrane platforms are involved in L. donovani infection of macrophages, we infected Leishmania-susceptible BALB/c-derived peritoneal macrophages with L. donovani and determined the distribution of sphingolipid-rich membrane domains by staining the cells with FITC-labeled cholera toxin (CTX-B-FITC), a well-known lipid raft marker that binds to the typical raft-associated ganglioside GM1 [32] . Within 1 hour of infection of macrophages with L. donovani promastigotes, a rapid fusion of the CTX-B-FITC + domains was triggered to generate larger platforms on the macrophage membrane. These CTX-B-FITC + domains started dispersing around 12 hours after infection and were unidentifiable 24 hours after the infection ( Figure 1A ). Similar observations were noted with another raft marker, anti-CD48-PE [33] ( Figure 1B ). These data show that the initial parasite-macrophage interaction triggers the reorganization of sphingolipidenriched membrane domains into larger platforms.
Sphingolipid-Rich Membrane Platforms Are Essential for L. donovani Internalization
To assess the significance of the formation of sphingolipid-rich rafts in the host cell membrane during the initial macrophageLeishmania interaction, we disrupted the rafts by preincubating BALB/c-derived peritoneal macrophages with nystatin or β-methyl cyclodextrin. α-cyclodextrin, the inactive isomer of βMCD, was used as a negative control. Disruption of sphingolipid-enriched rafts prevented the entry of L. donovani inside the host macrophages. We found that L. donovani infection of nystatin-or βMCD-pretreated macrophages but not of α-cyclodextrin-treated macrophages significantly decreased parasite internalization (P < .001) ( Figure 2A ). Because ceramide is a major sphingolipid that helps in the raft organization, we examined the role of ceramide in the raftmediated entry of Leishmania by enhancing raft formation with exogenous C16 ceramide (10 μM) or by inhibiting endogenous ceramide generation by use of the ASMase-specific inhibitor imipramine [34] . C16 ceramide significantly increased the parasite internalization (P < .001) ( Figure 2A ). In contrast, in Macrophages were cultured and infected with the promastigotes for indicated periods, as described in the legend of Figure 1 . ASMase activity was determined as described in Materials and Methods. Results are expressed as mean ± SD of 4 replicate experiments. Asterisks indicate statistically significant induction (*P < .003) of ASMase activity as compared to 0-hour infected cells. B, Surface ceramide reside inside the membrane rafts. Cells were stained with anti ASMase-FITC and anti-ceramide-PE and were observed under a confocal laserscanning microscope. Yellow fluorescence depicts colocalization. Results are representative of 3 independent experiments in which at least 100 cells per sample were analyzed. C, L. donovani infection triggers ceramide production in the host cells membrane. Cells were infected with promastigotes, and the membrane ceramide production was analyzed by flow cytometry. D, The cytosolic and membrane fractions were separated by ultracentrifugation, and the ceramide level was quantitated (see Materials and Methods). Results are expressed as mean ± SD of 3 replicate experiments. Asterisks indicate statistically significant induction of ceramide level as compared to 3-hour infected cells (*P < .001, **P < .005). E, L. donovani infection induces imipramine-treated cells, parasite internalization was significantly reduced (P < .001) (Figure 2A) , compared with the untreated cells. Likewise, parasite burden was significantly reduced in ASMase siRNA-transfected macrophages but not in the control siRNA-transfected macrophages (P < .005) ( Figure 2B ). These observations indicate that ASMase-generated ceramide is required for the raft-reliant internalization of the parasite.
L. donovani Infection Triggers Biphasic Induction of Ceramide in the Host Macrophage
Because ASMase can release ceramide from sphingomyelin in the membrane raft, we first examined whether L. donovani infection affected ASMase activity. We observed that ASMase activity started 30 minutes after the infection ( Figure 3A) . ASMase activity was almost undetectable in uninfected cells. The surface ceramide clustered in a pattern similar to that of ASMase, as confirmed by its colocalization with ASMase ( Figure 3B ). Flow cytometry analyses revealed a significantly higher amount of ceramide in the membrane of the infected cells as compared to the uninfected cells ( Figure 3C ). Although there was significantly enhanced ceramide production in the membrane of 3 hour-infected macrophages ( Figure 3D ), the ceramide levels gradually decreased to the basal level. The membrane ceramide level increased again in 24-hour-infected macrophages (P < .001) (Figure 3D ), suggesting a biphasic induction of ceramide in Leishmania-infected macrophages. This second wave of ceramide generation is due to the de novo synthesis. We observed that the activity of ceramide synthase, the main enzyme of de novo synthesis, started 12 hours after the infection ( Figure 3E ). Pretreatment of cells with FB1, a specific blocker of the de novo synthesis of ceramide, followed by infection for 24 hours, resulted in significant reduction in membrane ceramide level (P < .005). Interestingly, FB1 treatment did not affect the initial ceramide burst ( Figure 3D ). To conclusively prove that the retained ceramide at 24 hours is de novo synthesized, we radiolabeled sphingomyelin, the precursor of ASMase-dependent ceramide, and palmitoyl CoA, the precursor of de novo synthesized ceramide, and studied their retention in the cell membrane ( Figure 3F) . The results showed that the retained ceramide at 24 hours was indeed from de novo synthesis, because of the incorporation of radiolabeled C 14 from palmitoyl CoA, the precursor in the de novo synthesis pathway. Moreover, the generation of ceramide via ASMase stopped after 6 hours, so the retained ceramide at 24 hours was clearly from the de novo synthesis pathway and not from the sphingomyelin breakdown ( Figure 3F ). To examine whether ceramide was localized in the raft structure, we assessed colocalization of fluorescence-labeled anticeramide antibody and anti-CD48-PE antibody. The confocal microscopy revealed that ceramide moved inside the rafts ≤1 hour after infection ( Figure 3G ). Pretreatment of macrophages with imipramine resulted in the disappearance of ceramide microdomains from the membrane ( Figure 3H ). In contrast, 24 hours after the infection, the raft structure completely disappeared in spite of elevated ceramide levels in the host cell membrane. Pretreatment of macrophages with FB1, a selective inhibitor of the de novo pathway, reduced the ceramide level but recovered normal raft architecture ( Figure 3H ). Taken together, these data indicate that ceramide can be generated in at least 2 different modes, by ASMase and by FB1-sensitive de novo synthesis, which are involved, respectively, in the initial uptake of the parasite via the ceramide-enriched membrane domains and in the late function of the macrophages, where raft disruption may play an important role.
De novo-Synthesized Ceramide Reduces HMGCR Expression and Membrane Cholesterol in L. donovani-Infected Macrophages
The above-mentioned data present the paradox that although ceramide is necessary to form the raft structure, rafts are disrupted in the macrophages 24 hours after infection, despite the enhanced ceramide level in the membrane. We addressed this paradoxical role of ceramide in the modulation of raft in L. donovani-infected macrophages. Because cholesterol is a key component in the lipid raft, we first measured the total cellular and membrane cholesterol levels in the infected Figure 3 continued. the activation of ceramide synthase. Ceramide synthase activity was determined as described in Materials and Methods. Results are expressed as mean ± SD of 4 replicate experiments. Asterisks indicate statistically significant induction of ceramide synthase activity as compared to 0-hour infected cells (*P < .001, **P < .005). F, Radiolabeled sphingomyelin, the precursor of ASMase-dependant ceramide, and 14 C palmitoyl CoA, the precursor of de novo-synthesized ceramide, were taken up, and their retention in the cell membrane of L. donovani-infected peritoneal macrophages was studied. Briefly, 4 × 10 6 macrophages were labeled for 30 hours with [ ]-sphingomyelin. Cells were washed with sterile phosphate-buffered saline several times and resuspended in Roswell Park Memorial Institute medium. Cells were infected with L. donovani promastigotes. Total membrane lipids were extracted at 4°C with chloroform/methanol 2/1 (v/v). The radioactivity content of aliquots from CHCL 3 phases was determined by liquid scintillation counting, and equal amounts of radioactivity in each sample were applied to TLC and silica gel G plates (Whatman), along with standard ceramides. Plates were air dried, and lipid bands were identified. The bands corresponding to the standard were scraped, and radioactive counts were measured in a liquid scintillation counter with 4 mL Cocktail-O. Results are representative of 3 independent experiments. Asterisks indicate statistically significant induction of ceramide level (*P < .001, **P < .005). G, Cells were stained with anti CD48-PE and anti-ceramide-FITC and were observed under a confocal laser-scanning microscope. Yellow fluorescence depicts colocalization. Results are representative of 3 independent experiments in which at least 100 cells per sample were analyzed. H, Mouse peritoneal macrophages were treated with imipramine or FB1 and then infected with L. donovani. After culture for indicated periods, cells were stained with CTX-B-FITC and observed under confocal laser-scanning microscope. Results are representative of 3 independent experiments in which at least 100 cells per sample were analyzed. macrophages and the ceramide-treated uninfected macrophages. While L. donovani infection, exogenous ceramide, and imipramine significantly reduced both membrane and cellular cholesterol levels, FB1 did not exert similar effects ( Figure 4A ). It is possible that an enhanced ceramide concentration may reduce the cholesterol level in macrophages during L. donovani infection.
Because cell-permeable ceramide reduced the activity of HMGCR, the rate-limiting enzyme of cholesterol biosynthesis [35] , we studied the effect of ceramide on HMGCR expression.
We observed reduced HMGCR messenger RNA (mRNA) expression in L. donovani-infected or cell-permeable C2-ceramide treated macrophages ( Figure 4B ). However, imipraminetreated infected macrophages had unaltered HMGCR expression ( Figure 4B ). In contrast, FB1 pretreatment increased HMGCR mRNA expression in L. donovani-infected macrophages ( Figure 4B ). These data suggest that increased ceramide levels during the infection affected membrane cholesterol by at least 2 different mechanisms: reduced HMGCR expression and displacement of membrane cholesterol. Because cholesterol is a key component of membrane raft structure, our data imply that the enhanced ceramideaffected raft formation influences the receptor-ligand interaction that regulates cellular responsiveness to a given stimulus.
Enhanced Ceramide Increases the Membrane Fluidity but Decreases the Antigen Presentation by the Infected Macrophages
Because the FB1-sensitive de novo-synthesized ceramide extruded cholesterol from the membrane of the L. donovaniinfected macrophages, and because cholesterol is a major factor that regulates membrane fluidity, we examined whether the enhanced ceramide affected the membrane fluidity of the infected cells ( Figure 5A ). We measured FA as an indicator of membrane fluidity and observed that the FA was significantly diminished 24 hours after the infection ( Figure 5B ), suggesting enhanced fluidity of the membrane of L. donovani-infected macrophages. FB1 pretreatment of the infected macrophages restored the FA of the membrane in L. donovani-infected cells to the level observed in the uninfected macrophages ( Figure 5B ). These observations indicated that the elevated ceramide levels regulated membrane fluidity in the infected macrophages.
Because L. donovani infection impairs the antigenpresentation capability of macrophages, owing to enhanced membrane fluidity of the antigen-presenting cells [36] , we tested the role of de novo-generated ceramide on the antigenpresentation capability of the infected macrophages. We assessed the presentation of the λR [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] peptide by the uninfected and L. donovani-infected macrophages to the peptide-specific T cell hybridoma. It was observed that FB1 treatment of the infected macrophages significantly enhanced their antigenpresenting functions ( Figure 5C ).
Because major histocompatibility complex (MHC) class II molecules are constitutively present on the lipid rafts during antigen presentation [37] , we studied the colocalization of MHC class II (anti-I-A d ) molecules and CTX-B FITC.
Although MHC class II (anti-I-A d ) molecules were not colocalized with CTX-B in the infected macrophages, FB1 treatment brought these 2 groups of molecules together ( Figure 5A ), indicating that the enhanced intracellular ceramide disrupted lipid rafts and impaired antigen presentation by the infected macrophages. The results from the above-stated experiments clearly revealed the importance of ceramide-enriched membrane platforms and the intracellular ceramide level in the cellular uptake and intracellular survival, respectively, of the parasite. This prompted us to study whether disrupting the above 2 events could abrogate the intracellular parasitic growth in a host susceptible to L. donovani infection. Because both ASMase-and FB1-sensitive pathways of ceramide generation are equally important for this protozoan parasite, we studied the effect of ASMase siRNA, which reduces ASMase expression, and FB1, which reduces de novo ceramide synthesis, on the intracellular ceramide generation and subsequently on intracellular parasitic growth. L. donovani-infected BALB/c mice were either left untreated or were pretreated with ASMase siRNA or FB1, individually or in combination. We observed higher levels of ceramide generation in the splenic macrophages 7 and 21 days after L. donovani infection, compared with the uninfected control (P < .01) ( Figure 6A ). However, reduced ceramide levels in ASMase siRNA-treated, FB1-treated, or ASMase siRNA-and FB1-treated mice were observed in the splenic macrophages 7 and 21 days after the infection, compared with the only infected sets (P < .01) ( Figure 6A) ; the reduction was even stronger in the mice treated with ASMase siRNA plus FB1(P < .005) ( Figure 6A ).
Because ASMase siRNA and FB1 modulated ceramide levels in vivo, we examined whether these treatments conferred significant protection against L. donovani infection. ASMase siRNA treatment reduced the splenic parasite burden by 66% and 89% 7 days and 21 days, respectively, after the infection (P < .005) ( Figure 6B ). In contrast, FB1-pretreated mice showed no significant decrease in parasite burden 7 days after the infection, but a decrease of 80% was found 21 days after the infection (P < .005) ( Figure 6B ). Mice treated with ASMase siRNA plus FB1 had highly significant protection (75% and 93% reduced spleen parasitic burden 7 days and 21 days, respectively, after the infection; P < .005) ( Figure 6B ). Taken together, these data indicate for the first time that the rationale for the ceramide-targeted therapy of L. donovani infection is a spatiotemporal function of ceramide generation in the host cell.
DISCUSSION
Our observations reveal that Leishmania induces biphasic ceramide activation in the host cell. L. donovani attachment with macrophage membrane activates ASMase, which hydrolyzes Cells were infected with L. donovani promastigotes, and the fluorescence anisotropy (FA) was measured using Diphenylhexatriene as a probe. Results are expressed as mean ± SD of 5 replicate experiments. Asterisks indicate statistically significant inhibition as compared to control cells (*P < .003) and significant induction of FA as compared to infected cells (**P < .005). C, Enhanced ceramide decreases the antigen-presenting capability of infected macrophages. Normal and infected peritoneal MΦs from BALB/c mice were used as antigen-presenting cells to drive the 9H3.5 T-cell hybridoma in the presence of λR 12-26 peptide, and interleukin 2 (IL-2) secretion was tested on an IL-2-dependent cell line HT-2. The growth of HT-2 was studied using H3-thymidine incorporation. The figure shows IL-2-dependent proliferation of an IL-2-dependent T-cell line, which was calculated in terms of 3H-thymidine incorporation and represented as CPM. Results are expressed as mean ± SD of 5 replicate experiments. Asterisks indicate statistically significant inhibition as compared to control cells (*P < .005) and induction as compared to infected cells (**P < .005).
sphingomyelin to ceramide, thereby helping in the formation of the membrane microdomains responsible for Leishmania internalization [4] . However, the second phase of ceramide generation, by the FB1-sensitive de novo pathway, efficiently reduces cholesterol biosynthesis and displaces cholesterol from the lipid raft, resulting in impaired antigen-presentation by the L. donovani-infected macrophages. These data provide the first evidence that Leishmania-induced biphasic ceramide activation causes sequential association and disruption of the rafts at early and later phases, respectively, of the infection.
Our data reveal that ceramide-enriched membrane platforms are a crucial component during the early stages of hostparasite interaction. Ceramide spontaneously self-aggregates into microdomains and triggers fusion of microdomains into larger and more stable platforms, facilitating the entry of L. donovani inside the host cells [4, 5] . Restriction of parasite entry by silencing the ASMase gene or by using the pharmacological ASMase-inhibitor imipramine [34] indicates that, in addition to cholesterol, ceramide is crucial lipid that regulates the parasite internalization.
To establish the mechanism of ceramide-mediated raft disruption in the membrane, we studied the effect of ceramide on the cholesterol level in the membrane of the L. donovaniinfected macrophages. During infection, ceramide reduced not only membrane cholesterol but also cellular cholesterol ( Figure 4A and 4B) . While the reduction in cellular cholesterol might have been caused by the significantly reduced HMGCR expression in the infected macrophages [35] , the reduction in membrane cholesterol could result from the competition with ceramide to complex with other membrane lipids. For example, because both cholesterol and ceramide are hydrophobic, with the polar head groups much shorter than the other membrane phospholipids, they are generally nucleated inside the hydrophobic microenvironment in the membrane lipids. Very high ceramide biosynthesis in the L. donovaniinfected macrophages may alter the ceramide:cholesterol stoichiometric relationship with the other membrane phospholipids beyond the permissible range. Coupled with reduced cholesterol biosynthesis in L. donovani infection, ceramide drives the stoichiometry in its favor and thereby replaces cholesterol from the membrane [36] . However, the differences in the physicochemical properties between ceramide and cholesterol change the overall biophysical properties, such as anisotropy of the L. donovani-infected macrophage membrane, affecting T cell responses.
Indeed, increased membrane fluidity and disruption of lipid rafts inhibit the antigen-presentation capability of macrophages [37] . It appears that during the later phase of the infection, enhanced ceramide generation increased membrane fluidity and disrupted the lipid rafts. Thus, the anisotropy reduced with ceramide accumulation in the membrane ( Figure 5B ). Because MHC class II molecules are constitutively present inside the membrane lipid rafts and execute antigen presentation [29] , we studied the colocalization of MHC class II molecules and CTX-B-FITC. The failure of these 2 molecules to colocalize in infected cells suggests the disruption of lipid rafts due to an increased ceramide level in the macrophage membrane during the later phase of the infection. Indeed, recovery of the raft architecture by FB1 clearly Figure 6 . Acid sphingomyelinase (ASMase) siRNA and FB1 pretreatment impart significant resistance to Leishmania donovani infection in BALB/c mice. Mice were pretreated with either ASMase siRNA (100 µg/kg of body weight) or FB1 (10 mg/kg of body weight), followed by infection with L. donovani. Mice were sacrificed on days 7 and 21 after infection. A, Levels of ceramide production in the splenic macrophages were analyzed by flow cytometry. Asterisks indicate statistically significant reduction as compared to control cells (**P < .005). B, Levels of parasite burden in spleen; samples are expressed in Leishman-Donovan units (LDU). Results are from 3 independent experiments and represent the mean values ± standard errors of the means for 5 animals per group per time point. Asterisks indicate statistically significant reduction as compared to infected sets (**P < .005).
indicated that ceramide disrupted the lipid rafts, dissociated the MHC class II organization in rafts, and eventually impaired antigen presentation. This inability to present antigen may contribute to the defective cell-mediated immune response in L. donovani-infected BALB/c mice and favored survival of the parasite. Indeed, our in vivo experiments demonstrate that ASMase siRNA and FB1 treatment could significantly lessen the intracellular ceramide generation and could restrict the splenic parasite growth 7 days after the infection or for 21 days following infection. Other pathogens, such as Mycobacterium [38] , Pseudomonas [17] , Plasmodium [39] , Neisseria gonorrhoeae [16] , and human immunodeficiency virus [40] , also use rafts or raft-like structures for their internalization into their mammalian host cells, but the involvement of ceramide in these infections remains uncovered. Thus, unraveling the biphasic, spatiotemporal regulation of ceramide in L. donovani infection-both in vitro and in vivo-turns out to be the first prototype for the rationale for ceramide-targeted therapy for infectious diseases.
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